Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
This is a non-randomized, open label, dose-escalation study to evaluate the safety and efficacy of KL002 in the treatment of advanced primary Parkinson's disease. Condition or disease: Parkinson's Disease Intervention/treatment: Drug: KL002 Phase: NA
Official title: Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary Parkinson's Dissease
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
9
Start Date
2023-06-01
Completion Date
2026-06-30
Last Updated
2023-05-31
Healthy Volunteers
No
Conditions
Interventions
KL002 injection solution
Neurosurgical delivery of KL002 to the brain
Locations (1)
Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China